WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Akhilesh Mishra, Gayatri Dewangan*, Ramdas Singh, Amartya De,Jui Chakraborty and T.K. Mandal


Osteosarcoma is the most common primary tumor of bone, yet its absolute incidence among malignant tumors is low. Within its strict histologic definition, osteosarcoma comprises a family of lesions with considerable diversity in histologic features and grade. In most cases, typical radiographic features clearly illustrate the aggressive bone forming nature of the lesion. The successful treatment of patients with osteosarcoma requires close co-operation within an experienced multidisciplinary team including pediadric or medical oncologists, surgeons, physicians, pathologist and radiologists. Therapy must include complete surgical removal of all detectable tumor sites as well as multi-agent chemotherapy. Novel approaches are needed in order to improve their prognosis and developing to new targeted drug delivery techniques for less toxicity to the host. In this article we discuss clinical presentation, diagnosis, different types of treatment, health promotion and physico-chemical care for patients with osteosarcoma

Keywords: Chemotherapy, osteosarcoma, methotrexate, radiotherapy, targeted drug delivery

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More